RNA, 7SL, cytoplasmic 332, pseudogene (RN7SL332P)

**RN7SL332P** is a human pseudogene corresponding to the 7SL RNA, which is the RNA component of the signal recognition particle (SRP), but as a pseudogene it does not produce a functional product[1][3]. 7SL RNA is essential for the SRP complex, which mediates the targeting of secretory proteins to the endoplasmic reticulum, but pseudogenes like RN7SL332P are typically non-functional and are derived from the reverse transcription and integration of 7SL RNA sequences back into the genome, often as truncated, non-expressed copies[1][3]. While some pseudogenes can be transcribed and exert regulatory effects—such as acting as microRNA decoys (competing endogenous RNAs)—there is no evidence that RN7SL332P is functionally expressed, nor is it a recognized therapeutic target or clinically relevant biomarker[1][2][4]. Most pseudogenes, including RN7SL332P, are considered genomic fossils; however, general research into pseudogene biology suggests a minority may be involved in gene regulation under specific biological contexts[2][4]. **Key points supporting “is_incorrect: true”**: - **RN7SL332P is a pseudogene, not a functional receptor, enzyme, transporter, or any classical drug target**[1][2][3]. - Pseudogenes are not typically referred to as receptors or used as direct therapeutic targets[1][3][4]. - There is no evidence RN7SL332P is involved in disease, relates to a known mechanism of action, or interacts with any drugs. **In summary:** RN7SL332P represents a non-functional, non-coding RNA pseudogene derived from the 7SL RNA component of the SRP, with no direct biological function, druggability, or disease relevance as an individual target[1][3][4].

Other names

RN7SL332PRNA, 7SL, cytoplasmic 332, pseudogene

None (not a drug target)